INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Partnership Driving Superior Enrollment And Speed In Phase III Trial

  Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.

• Why Scalable EDC Systems Matter In Global Pharmaceutical Trials

  Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.

• Unlocking The Value Of AI In IRT: Practical Perspectives From Vendors

  AI can enhance IRT with predictive modeling and automation, but true success relies on high-quality data, compliance, and user trust. Learn practical strategies to boost efficiency.

• Is Your Legacy EDC Limiting AI's Impact On Your Clinical Data?

  AI can enhance clinical data workflows, but aging EDC systems hold teams back. This piece breaks down key barriers and shows what’s needed to modernize data foundations for meaningful AI adoption.

• Transforming Clinical Trial Disclosure With AI

  10/23/2024

  Unlock the full potential of AI to address sponsor challenges including regulatory complexity, clinical trial disclosure requirements, and growing demands for transparency.

• Connecting Travel And Payments To Support Trial Participation

  1/13/2026

  Optimize clinical trial success by simplifying patient travel and payments, and learn how removing logistical barriers ensures a more accessible experience for participants.

• Who Decides? Navigating AI Governance in Clinical Research

  6/15/2026

  AI in clinical research poses governance challenges. Clear ownership, consistent policies, and aligned teams help manage risk, ensure compliance, and drive responsible innovation in complex trials.

• A Day In The Life Of A Clinical Research Site

  4/22/2025

  Clinical research site coordinators are the unsung heroes of trial execution—managing complex protocols, supporting participants, and navigating fragmented systems, all while ensuring study integrity.

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  7/7/2025

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.